These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

427 related items for PubMed ID: 8911711

  • 21. Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer.
    Fox SB, Taylor M, Grøndahl-Hansen J, Kakolyris S, Gatter KC, Harris AL.
    J Pathol; 2001 Sep; 195(2):236-43. PubMed ID: 11592104
    [Abstract] [Full Text] [Related]

  • 22. Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta5-directed cell migration.
    Yebra M, Parry GC, Strömblad S, Mackman N, Rosenberg S, Mueller BM, Cheresh DA.
    J Biol Chem; 1996 Nov 15; 271(46):29393-9. PubMed ID: 8910604
    [Abstract] [Full Text] [Related]

  • 23. Biological significance of the expression of urokinase-type plasminogen activator receptors (uPARs) in brain tumors.
    Mohanam S, Gladson CL, Rao CN, Rao JS.
    Front Biosci; 1999 Feb 15; 4():D178-87. PubMed ID: 9989951
    [Abstract] [Full Text] [Related]

  • 24. Chemotactic effect of urokinase plasminogen activator: a major role for mechanisms independent of its proteolytic or growth factor domains.
    Poliakov AA, Mukhina SA, Traktouev DO, Bibilashvily RS, Gursky YG, Minashkin MM, Stepanova VV, Tkachuk VA.
    J Recept Signal Transduct Res; 1999 Nov 15; 19(6):939-51. PubMed ID: 10533982
    [Abstract] [Full Text] [Related]

  • 25. A hybrid protein of urokinase growth-factor domain and plasminogen-activator inhibitor type 2 inhibits urokinase activity and binds to the urokinase receptor.
    Ballance DJ, Marshall JM, Cottingham IR, Steven J, Berry SJ, Cederholm-Williams SA, Goodey AR, Courtney M.
    Eur J Biochem; 1992 Jul 01; 207(1):177-83. PubMed ID: 1321039
    [Abstract] [Full Text] [Related]

  • 26. The urokinase plasminogen activator and its receptor: role in cell growth and apoptosis.
    Alfano D, Franco P, Vocca I, Gambi N, Pisa V, Mancini A, Caputi M, Carriero MV, Iaccarino I, Stoppelli MP.
    Thromb Haemost; 2005 Feb 01; 93(2):205-11. PubMed ID: 15711734
    [Abstract] [Full Text] [Related]

  • 27. Plasminogen activator system, vascular endothelial growth factor, and colorectal cancer progression.
    Baker EA, Bergin FG, Leaper DJ.
    Mol Pathol; 2000 Dec 01; 53(6):307-12. PubMed ID: 11193049
    [Abstract] [Full Text] [Related]

  • 28. Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity.
    Czekay RP, Kuemmel TA, Orlando RA, Farquhar MG.
    Mol Biol Cell; 2001 May 01; 12(5):1467-79. PubMed ID: 11359936
    [Abstract] [Full Text] [Related]

  • 29. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
    Plesner T, Behrendt N, Ploug M.
    Stem Cells; 1997 May 01; 15(6):398-408. PubMed ID: 9402652
    [Abstract] [Full Text] [Related]

  • 30. Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator.
    Mahanivong C, Yu J, Huang S.
    Mol Carcinog; 2007 Mar 01; 46(3):165-75. PubMed ID: 17186542
    [Abstract] [Full Text] [Related]

  • 31. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
    Kobayashi H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug 01; 48(8):623-32. PubMed ID: 8808830
    [Abstract] [Full Text] [Related]

  • 32. Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer.
    Duggan C, Maguire T, McDermott E, O'Higgins N, Fennelly JJ, Duffy MJ.
    Int J Cancer; 1995 May 29; 61(5):597-600. PubMed ID: 7768629
    [Abstract] [Full Text] [Related]

  • 33. Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle.
    Nordengren J, Pilka R, Noskova V, Ehinger A, Domanski H, Andersson C, Høyer-Hansen G, Hansson SR, Casslén B.
    Mol Hum Reprod; 2004 Sep 29; 10(9):655-63. PubMed ID: 15243126
    [Abstract] [Full Text] [Related]

  • 34. Lysophosphatidylcholine induces urokinase-type plasminogen activator and its receptor in human macrophages partly through redox-sensitive pathway.
    Oka H, Kugiyama K, Doi H, Matsumura T, Shibata H, Miles LA, Sugiyama S, Yasue H.
    Arterioscler Thromb Vasc Biol; 2000 Jan 29; 20(1):244-50. PubMed ID: 10634825
    [Abstract] [Full Text] [Related]

  • 35. Kinetics of reciprocal pro-urokinase/plasminogen activation--stimulation by a template formed by the urokinase receptor bound to poly(D-lysine).
    Petersen LC.
    Eur J Biochem; 1997 Apr 15; 245(2):316-23. PubMed ID: 9151959
    [Abstract] [Full Text] [Related]

  • 36. Urokinase-type plasminogen activator supports liver repair independent of its cellular receptor.
    Shanmukhappa K, Sabla GE, Degen JL, Bezerra JA.
    BMC Gastroenterol; 2006 Nov 29; 6():40. PubMed ID: 17134505
    [Abstract] [Full Text] [Related]

  • 37. Urokinase plasminogen activator system: a multifunctional role in tumor progression and metastasis.
    Choong PF, Nadesapillai AP.
    Clin Orthop Relat Res; 2003 Oct 29; (415 Suppl):S46-58. PubMed ID: 14600592
    [Abstract] [Full Text] [Related]

  • 38. Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors.
    Gutova M, Najbauer J, Frank RT, Kendall SE, Gevorgyan A, Metz MZ, Guevorkian M, Edmiston M, Zhao D, Glackin CA, Kim SU, Aboody KS.
    Stem Cells; 2008 Jun 29; 26(6):1406-13. PubMed ID: 18403751
    [Abstract] [Full Text] [Related]

  • 39. Urokinase plasminogen activator amino-terminal peptides inhibit development of the rat ventral prostate.
    Elfman F, Bok R, Conn M, Shuman M, Cunha G.
    Differentiation; 2001 Dec 29; 69(2-3):108-20. PubMed ID: 11798065
    [Abstract] [Full Text] [Related]

  • 40. Role of fibrin and plasminogen activators in repair-associated angiogenesis: in vitro studies with human endothelial cells.
    van Hinsbergh VW, Koolwijk P, Hanemaaijer R.
    EXS; 1997 Dec 29; 79():391-411. PubMed ID: 9002228
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.